Literature DB >> 19118232

Pulmonary veno-occlusive disease in myeloproliferative disorder.

E Willems1, J-L Canivet, B Ghaye, L de Leval, M Radermecker, J-C Preiser, Y Beguin.   

Abstract

The present study reports a case of biopsy-proven pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a patient suffering from a chronic myeloproliferative disorder. The pulmonary disease evolved favourably under treatment with defibrotide, a pro-fibrinolytic medication used in hepatic veno-occlusive disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19118232     DOI： 10.1183/09031936.00157707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


  8 in total

1.  Whipple's disease-associated pulmonary hypertension with positive vasodilator response despite severe hemodynamic derangements.

Authors:  Salah Najm; Joud Hajjar; Robert P Nelson; Ramana S Moorthy; Karen M Wolf; Tim Lahm
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

Review 2.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

3.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

4.  Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm.

Authors:  Yalin Tolga Yaylali; Samet Yilmaz; Gulsum Akgun-Cagliyan; Oguz Kilic; Emrah Kaya; Hande Senol; Furkan Ozen
Journal:  Med Princ Pract       Date:  2020-02-19       Impact factor: 1.927

Review 5.  Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Authors:  Roberto F Machado; Harrison W Farber
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

6.  Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.

Authors:  Jiwon Kim; Spencer Krichevsky; Lola Xie; Maria Chiara Palumbo; Sara Rodriguez-Diego; Brian Yum; Lillian Brouwer; Richard T Silver; Andrew I Schafer; Ellen K Ritchie; Maria Mia Yabut; Claudia Sosner; Evelyn M Horn; Richard B Devereux; Joseph M Scandura; Jonathan W Weinsaft
Journal:  J Am Soc Echocardiogr       Date:  2019-10-03       Impact factor: 5.251

Review 7.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

8.  Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera.

Authors:  Takayoshi Tachibana; Naoki Nakayama; Ayako Matsumura; Yuki Nakajima; Hiroyuki Takahashi; Takuya Miyazaki; Hideaki Nakajima
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.